Center for Financial Planning’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Buy
3,816
+1,100
+41% +$92.1K 0.03% 135
2026
Q1
$217K Buy
2,716
+812
+43% +$66.9K 0.02% 164
2025
Q4
$162K Sell
1,904
-417
-18% -$34.2K 0.02% 188
2025
Q3
$181K Sell
2,321
-227
-9% -$17.7K 0.02% 177
2025
Q2
$199K Sell
2,548
-1,353
-35% -$101K 0.02% 166
2025
Q1
$283K Buy
3,901
+54
+1% +$3.87K 0.04% 135
2024
Q4
$285K Hold
3,847
0.04% 129
2024
Q3
$254K Hold
3,847
0.03% 135
2024
Q2
$355K Buy
3,847
+40
+1% +$3.54K 0.05% 109
2024
Q1
$364K Buy
3,807
+85
+2% +$7.14K 0.05% 111
2023
Q4
$284K Hold
3,722
0.05% 118
2023
Q3
$258K Buy
3,722
+694
+23% +$55.8K 0.06% 117
2023
Q2
$286K Hold
3,028
0.06% 112
2023
Q1
$251K Hold
3,028
0.06% 122
2022
Q4
$226K Buy
3,028
+655
+28% +$50.5K 0.05% 125
2022
Q3
$196K Hold
2,373
0.05% 122
2022
Q2
$226K Hold
2,373
0.06% 118
2022
Q1
$279K Hold
2,373
0.06% 112
2021
Q4
$307K Buy
2,373
+227
+11% +$26.5K 0.06% 108
2021
Q3
$243K Buy
2,146
+21
+1% +$2.4K 0.06% 113
2021
Q2
$220K Buy
2,125
+570
+37% +$53.7K 0.05% 120
2021
Q1
$130K Hold
1,555
0.03% 146
2020
Q4
$142K Buy
1,555
+500
+47% +$41.5K 0.04% 136
2020
Q3
$84K Buy
+1,055
New +$82.3K 0.03% 151

Other funds holding EW

Center for Financial Planning's EW Position: Q2 2026 in Review

Center for Financial Planning increased its Edwards Lifesciences (EW) stake by 41% in Q2 2026, buying an estimated $92.1K and bringing the position to 3,816 shares worth $345K. The position accounts for 0.03% of the portfolio, ranked #135.

Center for Financial Planning first reported a position in EW in Q3 2020 and has held it in 24 quarters since. The position peaked at $364K in Q1 2024. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Center for Financial Planning held 3,816 shares of Edwards Lifesciences worth $345K as of Q2 2026.
  • Center for Financial Planning bought 1,100 Edwards Lifesciences shares in Q2 2026, an estimated $92.1K.
  • Edwards Lifesciences made up 0.03% of Center for Financial Planning's portfolio in Q2 2026, its #135 holding.
  • Center for Financial Planning first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 24 quarters since.
  • Center for Financial Planning's Edwards Lifesciences position peaked at $364K in Q1 2024.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Center for Financial Planning's 13F filing for Q2 2026, filed 21 Jul 2026.